Leading Independent Advisory Firm Glass Lewis Joins ISS in Recommending Columbia Care Shareholders Vote FOR the Transaction with Cresco Labs

Author's Avatar
Jun 30, 2022

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., today announced that a second leading independent firm, Glass Lewis, has recommended that shareholders vote “FOR” the previously announced transaction with Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco”) at the Company’s upcoming Special Meeting of Shareholders (the “Special Meeting”) scheduled for July 8, 2022. Institutional Shareholder Services (“ISS”) has also recommended that shareholders vote in support of the transaction.